Patents Assigned to CARDINAL HEALTH SWITZERLAND 515 GmbH
  • Publication number: 20200008835
    Abstract: An atherectomy system that utilizes an anchoring balloon with a rotary debulker and a crossing balloon to remove or debulk lesions formed on the interior wall surface of a body vessel. The system may include a first balloon coupled to a first tubular member, a rotary debulker coupled to a second tubular member, a second balloon coupled to both the third tubular member and the axially moveable fourth tubular member such that the second balloon is disposed inside the third tubular member. Methods for operating this device are also provided.
    Type: Application
    Filed: December 4, 2017
    Publication date: January 9, 2020
    Applicant: Cardinal Health Switzerland 515 Gmbh
    Inventor: William David Kelly
  • Publication number: 20190374754
    Abstract: A dilator for sheathless access to a vessel of a patient having a tubular distal member with a skived portion on the proximal end and a proximal member with a skived portion on the distal end. The respective skived portions overlap at a transition region and form a rapid exchange port that communicates with the lumen of the distal member. The proximal member and the distal member may be secured together with transition tubing that is coaxially disposed over the distal and of the proximal member and extends over the skived portion of the distal member within a projected circumference of the distal member.
    Type: Application
    Filed: March 30, 2016
    Publication date: December 12, 2019
    Applicant: Cardinal Health Switzerland 515 Gmbh
    Inventor: Andrew Messenger
  • Patent number: 10376397
    Abstract: The present invention relates to tissue-supporting medical devices and drug delivery systems, and more particularly to tubular flexible stents that are implanted within a body lumen of a living animal or human to support the organ, maintain patency and/or deliver drugs or agents. The tubular flexible stent has a cylindrical shape defining a longitudinal axis and includes a helical section having of a plurality of longitudinally oriented strut members and a plurality of circumferentially oriented hinge members connecting circumferentially adjacent strut members to form a band. The band is wrapped about the longitudinal axis in a substantially helical manner to form a plurality of helical windings. At least one connector member extends between longitudinally adjacent helical windings of the band.
    Type: Grant
    Filed: September 21, 2015
    Date of Patent: August 13, 2019
    Assignee: CARDINAL HEALTH SWITZERLAND 515 GMBH
    Inventors: Ryan Donovan, John F. Shanley, Prasanna Muralidharan, David W. Overaker, Ramesh Marrey, Robert Burgermeister
  • Patent number: 10357275
    Abstract: An system for treating arterial occlusive disease with rotating cutting baskets whose outer diameter can be infinitely adjusted to adjust by the operator for precise excision of plaque buildup in the body vessel.
    Type: Grant
    Filed: June 26, 2015
    Date of Patent: July 23, 2019
    Assignee: CARDINAL HEALTH SWITZERLAND 515 GMBH
    Inventors: David Majercak, Wendy Ann Young
  • Patent number: 10349971
    Abstract: This disclosure is directed to systems and methods for providing a guiding device having a dilatable, drilling tip. The tip is formed by wound helical members such that resistance to rotation in an unwinding direction dilates the tip. The helical members are configured so that the dilatable tip increases in stiffness when the helical members are tensioned by a resistance to rotation in the winding direction. In some embodiments, application of relative force between coaxial inner and outer tubular members is used to control the dilation, stiffness and drilling of the guiding member.
    Type: Grant
    Filed: August 3, 2015
    Date of Patent: July 16, 2019
    Assignee: CARDINAL HEALTH SWITZERLAND 515 GMBh
    Inventor: Matthew Wilkinson
  • Patent number: 10335174
    Abstract: This disclosure is directed to systems and methods for re-entering the true lumen of a vessel. The re-entry catheters employ deflectable struts to stabilize and support the distal tip in a subintimal location while a passageway back into the true lumen is formed. Re-entry to the true lumen can be effected with a cutting element or with a conventional guidewire.
    Type: Grant
    Filed: April 1, 2016
    Date of Patent: July 2, 2019
    Assignee: CARDINAL HEALTH SWITZERLAND 515 GMBH
    Inventor: Matthew Wilkinson
  • Publication number: 20190125564
    Abstract: Various embodiments are described for a stent delivery device that utilizes a push button using a slot and pin on a shuttle with a rack for slow retraction of the outer sheath as well as a flanged member connected to the outer sheath for fast retraction of the outer sheath during delivery of a self-expanding implantable device such as a stent or stent graft.
    Type: Application
    Filed: October 24, 2018
    Publication date: May 2, 2019
    Applicant: Cardinal Health Switzerland 515 GmbH
    Inventor: Bruce Frohman
  • Publication number: 20190091047
    Abstract: A stent is formed from an at least partially cylindrical non-bioresorbable framework with a longitudinal zone of the stent that extends from the proximal end of the framework to the distal end and is defined by opposing longitudinal edges. A plurality of bioresorbable struts are secured to opposing longitudinal edges of the longitudinal zone. The bioresorbable struts hold the opposing longitudinal edges a first distance apart at an expanded deployed diameter to apposition the framework against a wall defining the vessel. After the stent is endothelialized, degradation of the bioresorbable struts causes the stent to contract to a reduced deployed diameter so that the opposing longitudinal edges are a second distance apart that is less than the first distance.
    Type: Application
    Filed: March 29, 2016
    Publication date: March 28, 2019
    Applicant: Cardinal Health Switzerland 515 Gmbh
    Inventor: Quentin Walsh
  • Patent number: 10231855
    Abstract: The present invention relates to tubular stents that are implanted within a body lumen. The stent has a cylindrical shape defining a longitudinal axis and includes a helical section and a closed endless ring section within the helical section. The helical section has of a plurality of longitudinally oriented strut members and a plurality of circumferentially oriented hinge members connecting circumferentially adjacent strut members to form a band, the band being wrapped about the longitudinal axis in a substantially helical manner to form a plurality of helical windings. The closed ring section interrupts the repeating helical pattern and separates the helical section into a proximal helical section and a distal helical section. The intermediate ring section includes a plurality of longitudinally oriented strut members and a plurality of circumferentially oriented hinge members connecting circumferentially adjacent strut members to form an endless ring.
    Type: Grant
    Filed: August 2, 2011
    Date of Patent: March 19, 2019
    Assignee: CARDINAL HEALTH SWITZERLAND 515 GMBH
    Inventor: Valeska Schroeder
  • Publication number: 20180333283
    Abstract: The present invention is directed to an intraluminal guiding device having an expandable guiding member so as to facilitate and overcome the difficulties associated with obtaining contra-lateral leg access of a bifurcated stent or a bifurcated stent graft with a second guidewire and a method for treating abdominal aortic aneurysms with such a device. The guiding device comprises a pre-loaded second wire positioned within the contra-lateral leg which facilitates access to said leg in accordance with the present invention.
    Type: Application
    Filed: July 30, 2018
    Publication date: November 22, 2018
    Applicant: CARDINAL HEALTH SWITZERLAND 515 GMBH
    Inventor: James A. Fleming
  • Patent number: 10130384
    Abstract: A catheter system and corresponding methods are provided for accessing a blood vessel true lumen from a sub-intimal plane of the vessel. The catheter includes components that are symmetric about the longitudinal axis and allow for reentry without the need to ensure a correct orientation of the cannula.
    Type: Grant
    Filed: September 23, 2014
    Date of Patent: November 20, 2018
    Assignee: CARDINAL HEALTH SWITZERLAND 515 GMBH
    Inventor: David Majercak
  • Patent number: 10117764
    Abstract: Implantable medical devices may be utilized to locally delivery one or more drugs or therapeutic agents to treat a wide variety of conditions, including the treatment of the biological organism's reaction to the introduction of the implantable medical device. These therapeutic agents may be released under controlled and directional conditions from a stent having reservoirs so that the one or more therapeutic agents reach the correct target area, for example, the surrounding tissue. Features may be incorporated into the walls and bases of these reservoirs to improve securement of the drug construct.
    Type: Grant
    Filed: October 29, 2010
    Date of Patent: November 6, 2018
    Assignee: CARDINAL HEALTH SWITZERLAND 515 GMBH
    Inventors: Salvatore G. Caldarise, Carl J. Evens
  • Patent number: 10039657
    Abstract: The present invention is directed to an intraluminal guiding device having an expandable guiding member so as to facilitate and overcome the difficulties associated with obtaining contra-lateral leg access of a bifurcated stent or a bifurcated stent graft with a second guidewire and a method for treating abdominal aortic aneurysms with such a device. The guiding device comprises a pre-loaded second wire positioned within the contra-lateral leg which facilitates access to said leg in accordance with the present invention.
    Type: Grant
    Filed: March 15, 2013
    Date of Patent: August 7, 2018
    Assignee: CARDINAL HEALTH SWITZERLAND 515 GMBH
    Inventor: James A. Fleming
  • Patent number: 10029034
    Abstract: The present invention relates to drug-eluting articles with multiple polymeric coatings arranged and constructed to provide improved drug release profiles. Specifically, the present invention relates to drug-eluting articles that each comprises a substrate, a first polymeric layer over said substrate, and a second polymeric layer over said first polymeric layer. The first polymeric layer comprises at least a first biocompatible polymer and at least a first pharmacologically active compound that is encapsulated in the first biocompatible polymer. The second polymeric layer comprises at least a second biocompatible polymer having a degradability that is higher than that of the first biocompatible polymer.
    Type: Grant
    Filed: December 15, 2005
    Date of Patent: July 24, 2018
    Assignee: Cardinal Health Switzerland 515 Gmbh
    Inventors: Robert Falotico, Jonathon Z. Zhao
  • Patent number: 9987156
    Abstract: An endoprosthesis delivery system includes a wire holder on a distal section of an elongated shaft with a plurality of wires extending distally from the wire holder and, in a secured position, terminating in a distal receiver attached to the elongated shaft distal to the wire holder. A single wire attached to the wire holder and extending proximally along the delivery system to a point easily accessible by the operator may be pulled proximally to move the wires out of the distal receiver and release the endoprosthesis.
    Type: Grant
    Filed: June 24, 2014
    Date of Patent: June 5, 2018
    Assignee: CARDINAL HEALTH SWITZERLAND 515 GMBH
    Inventor: Cesar Alberto Rincon
  • Patent number: 9687262
    Abstract: This invention provides methods, devices and kits for treating coronary artery disease, particularly “soft” or vulnerable plaque. The invention is based on the local delivery of crosslinking means to crosslink the collagen covering the plaque and other proteins that may be present at the site to stabilize the plaque and prevent leakage of thrombogenic material into the lumen of the coronary artery. In certain embodiments, catheters are employed to achieve local delivery of a crosslinking agent or ultraviolet light.
    Type: Grant
    Filed: November 30, 2005
    Date of Patent: June 27, 2017
    Assignee: Cardinal Health Switzerland 515 GmbH
    Inventors: Robert A. Rousseau, Kevin S. Weadock
  • Patent number: 9655602
    Abstract: This invention relates to apparatus and methods used to seal a vascular puncture site, particularly sites of punctures that are the result of catheterization or other interventional procedures. The sealing device includes a sealing member and a tether. The sealing member occupies a space in an incision, puncture, or other wound and sealing the space that it occupies, to prevent further blood flow. The tether is attached to the sealing member, and provides the user with the ability to withdraw the sealing member if necessary. The sealing device further includes a restraining member associated with the sealing member. The restraining member provides the ability to more securely restrain the sealing member to prevent it from migrating from the deployment location within a tissue tract. The restraining member also provides an additional capability of manipulating the sealing member after deployment.
    Type: Grant
    Filed: December 15, 2011
    Date of Patent: May 23, 2017
    Assignee: Cardinal Health Switzerland 515 GmbH
    Inventors: Richard Ginn, Thomas Palermo, Phil Olsen, Tellis Hartridge, Adam Shively
  • Patent number: 9603980
    Abstract: Medical devices, and in particular implantable medical devices, may be coated to minimize or substantially eliminate a biological organism's reaction to the introduction of the medical device to the organism. The medical devices may be coated with any number of biocompatible materials. Therapeutic drugs, agents or compounds may be mixed with the biocompatible materials and affixed to at least a portion of the medical device. These therapeutic agents or compounds may also further reduce a biological organism's reaction to the introduction of the medical device to the organism. In addition, these therapeutic drugs, agents and/or compounds may be utilized to promote healing, including the prevention of thrombosis. The drugs, agents, and/or compounds may also be utilized to treat specific disorders, including vulnerable plaque, and atherosclerosis in type 2 diabetic patients. Therapeutic agents may also be delivered to the region of a disease site.
    Type: Grant
    Filed: February 26, 2008
    Date of Patent: March 28, 2017
    Assignee: Cardinal Health Switzerland 515 GmbH
    Inventor: Jonathon Z. Zhao
  • Patent number: 9561310
    Abstract: The present invention includes biocompatible polymeric coatings, membranes, matrices, and films to be used with implantable medical devices. Medical devices containing such materials applied to a surface thereof contain a film-forming fluorous homo-polymer or copolymer containing the polymerized residue of a fluorous moiety, wherein the relative amounts of the polymerized residues of one or more moieties are effective to provide the coating and films with properties effective for use in coating implantable med devices.
    Type: Grant
    Filed: October 27, 2014
    Date of Patent: February 7, 2017
    Assignee: Cardinal Health Switzerland 515 GmbH
    Inventor: Jonathon Z. Zhao
  • Patent number: D806230
    Type: Grant
    Filed: August 28, 2014
    Date of Patent: December 26, 2017
    Assignee: CARDINAL HEALTH SWITZERLAND 515 GMBH
    Inventors: Greg Johnson, Patrick Swindon, Omar Vakharia